REPL
Replimune Group, Inc. - Common Stock (REPL)
$08
About Replimune Group, Inc. - Common Stock (REPL)
Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.
Details
Daily high
$20.57
Daily low
$19.33
Price at open
$20.57
52 Week High
$21.26
52 Week Low
$1.50
Market cap
2.0B
Dividend yield
-
Volume
1.8M
Avg. volume
2.9M
P/E ratio
-7.09
Replimune Group, Inc. - Common Stock News
Details
Daily high
$20.57
Daily low
$19.33
Price at open
$20.57
52 Week High
$21.26
52 Week Low
$1.50
Market cap
2.0B
Dividend yield
-
Volume
1.8M
Avg. volume
2.9M
P/E ratio
-7.09